glp 1 and thirst Dehydration from GLP-1 Injections glp 1 water intake Stay
Description
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
Or the first couple weeks
Gastrointestinal symptoms and occasional psychiatric concerns require monitoring
Food and Drug Administration (FDA)-approved diabetes drug in 2005 by John Eng, with collaboration from Amylin Pharmaceutical (San Diego, CA, USA)
Practical implementation is what actually produces results
